Teva Announces Appointment of Richard Francis as President and CEO... and more - Life Science Headlines November 28, 2022
Cari Kraft
Top 10% LinkedIn Recruiter, Medical Device Recruiter, Pharmaceutical Recruiter, Biotechnology Recruiter - ckraft@jacobsmgt.com; Career Igniter, Publisher HS&M
Teva Announces Appointment of Richard Francis as President and CEO Tel Aviv, Israel, November 21, 2022 (Business Wire) -- Teva Pharmaceutical Industries Ltd. (“Teva” or the “Company”) (NYSE and TASE: TEVA), today announced that the Company’s Board of Directors has appointed Richard Francis as President and Chief Executive Officer, effective January 1, 2023.
FogPharma Announces $178 Million Series D Financing to Advance Helicon Polypeptide Therapeutics Cambridge, MA, November 21, 2022 (Business Wire) -- FogPharma®, a biopharmaceutical company pioneering a new class of precision medicines that could ultimately prove applicable to the vast majority of therapeutic targets, including those previously considered “undruggable,” today announced a $178 Million Series D financing.
Invacare Appoints Geoff Purtill President and Chief Executive Officer Elyria, OH, November 21, 2022 (Business Wire) -- Invacare Corporation (NYSE: IVC) announced today that its Board of Directors has named Geoffrey P. Purtill as President and Chief Executive Officer, roles that he has served on an interim basis since August 28, 2022.
Recommended by LinkedIn
Bonum Therapeutics Announces a $93M Series A Financing for Conditionally Active Therapies Seattle, WA, November 15, 2022 (Business Wire) -- Bonum Therapeutics, a biopharmaceutical company using allosteric regulation to create conditionally active and less toxic medicines, today announced a $93 million Series A financing.
Oxford Biomedica Appoints Dr Frank Mathias as Chief Executive Officer Oxford, UK, November 22, 2022 (Yahoo) -- Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica” or “the Company”), a leading gene and cell therapy group, today announces the appointment of Dr Frank Mathias as Chief Executive Officer (CEO) and Board Director, effective March 2023.
About the Author: Cari Kraft is the CEO of Jacobs Management Group, an Advisory Board Member at Experts OnTap, and the Publisher of Healthcare Sales and Marketing Magazine. Cari and her team specialize in placing top talent with Medical Device, Biotechnology, and Pharmaceutical companies nationwide.